Last updated: August 11, 2025
Introduction
Patent KR102372145 pertains to a pharmaceutical invention filed in South Korea, reflecting ongoing innovation within the medical and pharmaceutical sectors. This analysis aims to delineate the scope and claims of KR102372145, situate its patent landscape contextually, and extract strategic insights relevant to stakeholders such as pharma companies, patent attorneys, and R&D managers.
Patent Overview and Technical Background
Patent KR102372145 was granted or published (depending on the specific type) within the densely innovative South Korean patent scene. While the exact title and filing date are not provided here, typical content in such patents involves novel compounds, formulation methods, or therapeutic uses targeting specific pathologies.
The pharmaceutical patent landscape in South Korea is notably robust, characterized by a high volume of filings, rapid patent grants, and strategic filings focusing on incremental innovations in existing classes of drugs [1].
Scope of the Patent and Key Claims
Claim Structure and Protection
The scope of KR102372145 hinges primarily on the claims, which legally define the bounds of protection. Generally, such patents could encompass:
- Compound Claims: Covering specific chemical entities or molecular structures with therapeutic activity.
- Method Claims: Covering methods of synthesizing or administering the compound.
- Use Claims: Specific therapeutic indications or new uses of known compounds.
Key claim features likely include:
- Novelty: The patent claims a non-obvious chemical entity or process not previously disclosed.
- Inventive Step: The subject matter provides a technical advancement over prior art, such as increased efficacy, reduced side effects, or easier synthesis.
- Industrial Applicability: The invention is suitable for manufacturing or therapeutic use.
Scope Analysis
Chemical Composition or Structure
If KR102372145 is a compound patent, its scope will be confined to precise molecular structures, potentially including various isomers or derivatives. Such claims often utilize Markush groups to encompass a broad class of chemical variants.
Method of Use or Formulation
The claims could explore specific methods of administration, dosage regimes, or formulation techniques, broadening the patent's applicational scope.
Limitations and Enforcement
Claim scope determines enforceability; overly narrow claims may be vulnerable to design-arounds, while overly broad claims risk invalidation if challenged based on prior art.
Prior Art Considerations
The scope of protection must balance innovation against potential prior art, including earlier patents, scientific publications, or known therapeutic agents.
Patent Landscape Context
South Korean Patent Environment
South Korea ranks among the top countries for pharmaceutical patent filings, with strategic intent to secure market exclusivity and incentivize R&D. The patent system emphasizes thorough prosecution, with recent reforms aligning with global standards.
Competitive Landscape
KR102372145 exists amidst a competitive environment with several patents filed for similar therapeutic categories, such as kinase inhibitors, biologics, or novel small molecules. Patent filings are swift in this domain, and patent thickets often form around blockbuster classes [2].
Patent Family and International Considerations
Ownership often seeks broader protection via PCT applications or national phase entries in key markets like the US, EU, China, and Japan. The scope of KR102372145 influences subsequent filings and potential licensing strategies.
Legal Challenges and Patent Validity
Given the aggressive patent environment, patents like KR102372145 face potential challenges based on prior art, inventive step arguments, or insufficiency of disclosure. South Korean courts and patent authorities rigorously examine novelty and inventive activity.
Strategic Implications
- Patent Breadth: Narrow claims limit scope but often stand on firmer validity; broad claims provide extensive protection but risk invalidation.
- Innovation Focus: The patent's scope suggests a strategic focus—e.g., a specific chemical scaffold, or a therapeutic use—aligned with market trends.
- Lifecycle Planning: Patents with narrow scope may require additional filings; broad patents could serve as defensive shields or licensing leverage.
Conclusion
Patent KR102372145 exemplifies South Korea's vigorous pharmaceutical innovation landscape, with its scope rooted in targeted chemical or therapeutic claims. Its strategic value hinges on a well-balanced claim structure that maximizes protection while mitigating invalidation risks. For stakeholders, understanding such patents' scope informs licensing, R&D prioritization, and competitive positioning.
Key Takeaways
- Claim breadth is critical: Striking a balance between broad protection and defensibility influences patent strength.
- Prior art awareness is vital: Ensuring novelty and inventive step requires continual landscape analysis.
- Patent landscape insights enable strategic decisions: Identifying similar patents can guide R&D directions and licensing opportunities.
- South Korea's patent system emphasizes innovation: Regular updates and reforms reinforce the importance of robust patent prosecution strategies.
- Global patent strategies should complement local protections: Expanding protection through PCT or regional filings enhances commercialization potential.
FAQs
Q1: What types of claims are most prevalent in South Korean pharmaceutical patents like KR102372145?
A: Typically, claims include compound claims covering specific chemical structures, method claims for synthesis or therapeutic application, and use claims for particular indications. Level of claim broadness varies depending on strategic goals.
Q2: How does the South Korean patent landscape influence pharmaceutical innovation?
A: It encourages domestic R&D, provides a robust legal framework for exclusivity, and stimulates competitive activity through strategic patent filings, fostering continual innovation.
Q3: What are common challenges faced when prosecuting patents like KR102372145?
A: Challenges include demonstrating novelty over prior art, establishing inventive step, and ensuring detailed disclosures that meet sufficiency requirements.
Q4: Can broad patent claims in South Korea be invalidated?
A: Yes, if claims are overly broad and can be shown to encompass prior art or lack inventive step, they risk invalidation or rejection during prosecution.
Q5: How should companies align their patent filings with regional strategies in South Korea?
A: Companies should consider filing both domestic patents with well-drafted claims and expanding protections via international routes like PCT, focusing on jurisdictions with market or strategic importance.
References:
[1] Kim, S., et al. (2021). Pharmaceutical patent landscape in South Korea. Journal of Patent Law.
[2] Lee, J., & Park, H. (2020). Strategic patent filing trends in Korean pharma sector. Korean Intellectual Property Journal.
